AI Medical Technology’s smartphone-based software outperforms dermatologists in clinical trials; European commercial launch begins ahead of U.S. operations in 2027 STOCKHOLM, May 27, 2025 /PRNewswire/ — AI Medical Technology (AIM) has received CE mark approval for Dermalyser, its…
